powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1922153071
Samuel Merrick
M.D.
Internal Medicine
New York,
NY
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
91
Unique beneficiaries
—
Total services
200
Distinct HCPCS
3
Medicare payment
$13K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 7,864 Internal Medicine providers in NY — bottom quintile (cohort median 552).
PRESCRIBING · PART D · 2024
Total Rx claims
6,147
Beneficiaries
—
Total drug cost
$4.6M
Distinct drugs
134
Brand share
42.8%
Top prescribed drugs
Bictegrav/Emtricit/Tenofov Ala
363 claims
Atorvastatin Calcium
234 claims
Gabapentin
193 claims
Amlodipine Besylate
183 claims
Albuterol Sulfate
171 claims
QUALITY · MIPS · 2024
Final MIPS score
100.0
Quality
85.3
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
1.05%
APM Entity
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
